THERAPEUTICSMD INC TXMD
ASignal's systematic analysis rates TXMD as Bearish.
Reflects the latest available analysis · analyzed Nov 9, 2026
The case on TXMD
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.90)
- Low debt-to-equity ratio (0.20x)
- Positive free cash flow ($896,625)
- High gross margin (100.00%)
- Current ratio (3.22x) indicates solid liquidity
- Negative operating margin (-32.22%)
- Negative ROE (-1.08%) and ROA (-2.88%)
- Declining revenue and earnings (YoY: -8.70%, -80.60%)
- Negative EV/EBITDA (-12.06x) suggests financial distress or unprofitability
- Price below both SMA20 and SMA50, indicating downtrend
- No news coverage or Reddit mentions, indicating low market interest
See the full verdict on TXMD
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TXMD
Most investors never get a second opinion, let alone several. ASignal runs TXMD past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.